ImmunityBio, Inc. (FRA:26CA)

ImmunityBio Revenue

ImmunityBio had revenue of $32.06M USD in the quarter ending September 30, 2025, with 425.07% growth. This brings the company's revenue in the last twelve months to $82.56M, up 1,025.95% year-over-year. In the year 2024, ImmunityBio had annual revenue of $14.75M with 2,270.58% growth.

• Revenue (ttm): $82.56M
• Revenue Growth: +1,025.95%
• P/S Ratio: 24.85
• Revenue / Employee: $121.40K
• Employees: 680
• Market Cap: 1.75B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	14.75M	14.12M	2,270.58%
Dec 31, 2023	622.00K	382.00K	159.17%
Dec 31, 2022	240.00K	-694.00K	-74.30%
Dec 31, 2021	934.00K	329.00K	54.38%
Dec 31, 2020	605.00K	-1.60M	-72.52%
Dec 31, 2019	2.20M	2.16M	4,585.11%
Dec 31, 2018	47.00K	2.00K	4.44%
Dec 31, 2017	45.00K	1,000.00	2.27%
Dec 31, 2016	44.00K	-192.00K	-81.36%
Dec 31, 2015	236.00K	-405.00K	-63.18%
Dec 31, 2014	641.00K	41.00K	6.83%
Dec 31, 2013	600.00K	-	-